| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |